A detailed history of Nuveen Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 359,563 shares of UTHR stock, worth $134 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
359,563
Previous 434,514 17.25%
Holding current value
$134 Million
Previous $138 Million 6.91%
% of portfolio
0.04%
Previous 0.04%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $23.3 Million - $27.2 Million
-74,951 Reduced 17.25%
359,563 $129 Million
Q2 2024

Aug 09, 2024

SELL
$228.26 - $319.04 $6.93 Million - $9.69 Million
-30,360 Reduced 6.53%
434,514 $138 Million
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $5.61 Million - $6.64 Million
-26,631 Reduced 5.42%
464,874 $107 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $4.7 Million - $5.62 Million
-21,876 Reduced 4.26%
491,505 $108 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $7.8 Million - $9.14 Million
36,801 Added 7.72%
513,381 $116 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $2.94 Million - $3.34 Million
14,316 Added 3.1%
476,580 $105 Million
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $4.9 Million - $6.36 Million
-23,024 Reduced 4.74%
462,264 $104 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $5.17 Million - $7.04 Million
-25,106 Reduced 4.92%
485,288 $135 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $1.31 Million - $1.57 Million
6,420 Added 1.27%
510,394 $107 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $9.48 Million - $13.1 Million
-54,258 Reduced 9.72%
503,974 $119 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $6.14 Million - $7.91 Million
-36,966 Reduced 6.21%
558,232 $102 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $8.51 Million - $9.97 Million
-46,146 Reduced 7.2%
595,198 $129 Million
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $5.36 Million - $6.4 Million
-29,799 Reduced 4.44%
641,344 $118 Million
Q2 2021

Aug 16, 2021

SELL
$170.47 - $211.93 $1.48 Million - $1.84 Million
-8,667 Reduced 1.27%
671,143 $120 Million
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $4.44 Million - $5.04 Million
-28,835 Reduced 4.07%
679,810 $114 Million
Q4 2020

May 17, 2021

BUY
$101.87 - $151.79 $21.5 Million - $32 Million
211,087 Added 42.42%
708,645 $108 Million
Q4 2020

Feb 16, 2021

SELL
$101.87 - $151.79 $23.7 Million - $35.3 Million
-232,322 Reduced 31.83%
497,558 $75.5 Million
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $4.09 Million - $4.96 Million
-40,956 Reduced 5.31%
729,880 $73.7 Million
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $517,210 - $701,698
-5,577 Reduced 0.72%
770,836 $93.3 Million
Q1 2020

May 14, 2020

BUY
$79.39 - $115.35 $20.3 Million - $29.4 Million
255,101 Added 48.93%
776,413 $73.6 Million
Q4 2019

Feb 14, 2020

BUY
$78.31 - $95.34 $6.56 Million - $7.99 Million
83,815 Added 19.16%
521,312 $45.9 Million
Q3 2019

Nov 14, 2019

BUY
$74.85 - $85.99 $17.9 Million - $20.6 Million
239,056 Added 120.47%
437,497 $34.9 Million
Q2 2019

Aug 15, 2019

BUY
$76.06 - $120.81 $14.7 Million - $23.4 Million
193,777 Added 4154.74%
198,441 $15.5 Million
Q3 2018

Nov 13, 2018

BUY
$113.81 - $129.46 $47,572 - $54,114
418 Added 9.84%
4,664 $596,000
Q1 2018

May 14, 2018

SELL
$107.21 - $151.94 $1.34 Million - $1.9 Million
-12,500 Reduced 74.64%
4,246 $477,000
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $1.48 Million - $1.89 Million
12,500 Added 294.39%
16,746 $0
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $486,591 - $580,895
4,246
4,246 $498,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.